Who is sponsoring NCT05403879?

NCT05403879 is sponsored by Mansoura University.

What drugs are being tested in NCT05403879?

Interventions in NCT05403879: fixation of greater tuberosity fractures.

What condition does NCT05403879 study?

NCT05403879 studies Greater Tuberosity Fractures.

Is NCT05403879 still recruiting?

NCT05403879 is currently completed. Last updated 3 January 2024.

Last reviewed 2024-01-03 · How we verify

NCT05403879

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Modified Hook Wiring Technique for Greater Tuberosity Fractures, a Prospective Study

Completed NA Last updated 3 January 2024

What this trial tests

NA trial testing fixation of greater tuberosity fractures in Greater Tuberosity Fractures in 10 participants. Completed in 30 December 2023.

Timeline

23 March 2022

Primary endpoint
30 December 2023

30 December 2023

Quick facts

Lead sponsor	Mansoura University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	10
Start date	23 March 2022
Primary completion	30 December 2023
Estimated completion	30 December 2023
Sites	1 location across Egypt

Drugs / interventions tested

fixation of greater tuberosity fractures

Conditions studied

Greater Tuberosity Fractures — all drugs for Greater Tuberosity Fractures →

Sponsor

Mansoura University

Who can join

Adults 18 to 50, any sex, with Greater Tuberosity Fractures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the purpose of this study is to assess functional and radiological outcome of open reduction and internal fixation of isolated displaced greater tuberosity fractures (more than 5mm displacement) in adults advocating modified hook wiring with a follow-up period of one year.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Modified Hook Wiring Technique for Greater Tuberosity Fractures: A Prospective Study.
Elshahhat A, Nour K. · · 2025 · PMID 40878734 · DOI 10.52628/91.2.13849

Verify or expand the search:

Other Mansoura University trials

Trials by the same sponsor.

NCT05785377 — Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
NCT07509567 — Conventional Palatal Crib Versus Bonded Spurs for Anterior Open Bite Treatment · NA · not yet recruiting
NCT07393178 — Efficacy & Safety of High Power vs. Low Power Holmium Laser in Mini-PCNL for Large Renal Stones · NA · not yet recruiting
NCT07436182 — Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. · Phase 4 · not yet recruiting
NCT07534943 — Effectiveness of Oleanolic Acid as Intracanal Medicament on Infectious/Inflammatory Contents in Teeth With Apical Period · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05403879 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mansoura University
Last refreshed: 3 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05403879.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing